Zobrazeno 1 - 10
of 37
pro vyhledávání: '"CJM Melief"'
Autor:
Sm Mangsbo, Jasper Dinkelaar, Riccardo Castelli, Cjm Melief, Ferdinand Antonius Ossendorp, Robert A. Cordfunke, W.W.C. van Maren, Jdc Codee, G. A. Van Der Marel, Erika Fletcher, J. W. Drijfhout
Publikováno v:
Cancer Immunology Research. 4:PR01-PR01
The ability of dendritic cells (DCs) to boost an antigen-specific immune response is utilized in several cancer immunotherapy strategies including therapeutic vaccination using long peptides. Water-based peptide vaccines are rapidly degraded and oil-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::313351338b7d06187193db0dd2270283
https://doi.org/10.1158/2326-6066.imm2016-pr01
https://doi.org/10.1158/2326-6066.imm2016-pr01
Autor:
LT Vlasveld, A Hekman, FA Vyth-Dreese, EM Rankin, JGM Scharenberg, AC Voordouw, JJ Sein, TAM Dellemijn, S Rodenhuis, CJM Melief
Publikováno v:
British Journal of Cancer. 68:559-567
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b63a35da4ab9a8fd60b4325717d2e393
https://doi.org/10.1038/bjc.1993.386
https://doi.org/10.1038/bjc.1993.386
Publikováno v:
Leukemia Research. 9:1099-1104
Lymphocyte function-associated antigen 1 (LFA-1) is a membrane glycoprotein involved in a wide variety of functional activities mediated by human leukocytes. For example, expression of LFA-1 is required on immunoregulatory lymphocytes for functional
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d060ae26a4236b875f7a7545b53015f1
https://doi.org/10.1016/0145-2126(85)90098-0
https://doi.org/10.1016/0145-2126(85)90098-0
Autor:
Ce, Gómez, Perdiguero B, Jiménez V, Filali-Mouhim A, Ghneim K, Ek, Haddad, Ed, Quakkerlaar, Delaloye J, Alexandre Harari, Roger T, Dunhen T, Rp, Sékaly, Cjm, Melief, Calandra T, Sallusto F, Lanzavecchia A, Wagner R, Pantaleo G, Esteban M
Publikováno v:
Europe PubMed Central
Alexandre Harari
Alexandre Harari
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2adbd390b3fc9db8b5c51b55bacc8797
http://europepmc.org/abstract/PMC/PMC3359381
http://europepmc.org/abstract/PMC/PMC3359381
Autor:
van der Sluis TC; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands R.Arens@lumc.nl T.C.van_der_Sluis@lumc.nl., van Haften FJ; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands., van Duikeren S; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands., Pardieck IN; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands., de Graaf JF; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands., Vleeshouwers W; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands., van der Maaden K; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands., Melief CJM; ISA Pharmaceuticals, Oegstgeest, The Netherlands., van der Burg SH; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Arens R; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands R.Arens@lumc.nl T.C.van_der_Sluis@lumc.nl.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Nov 29; Vol. 11 (11). Date of Electronic Publication: 2023 Nov 29.
Autor:
Gosens KCM; Amsterdam UMC, University of Amsterdam, Department of Internal Medicine, Division of Infectious Diseases, Amsterdam, the Netherlands.; Amsterdam UMC, University of Amsterdam, Department of Dermatology, Amsterdam Institute for Infection and Immunity (AI&II), Amsterdam, the Netherlands., van der Burg SH; Leiden University Medical Center, Department of Medical Oncology, Oncode Institute, Leiden, the Netherlands., Welters MJP; Leiden University Medical Center, Department of Medical Oncology, Oncode Institute, Leiden, the Netherlands., Boekestijn S; Leiden University Medical Center, Department of Medical Oncology, Oncode Institute, Leiden, the Netherlands., Loof NM; Leiden University Medical Center, Department of Medical Oncology, Oncode Institute, Leiden, the Netherlands., Quint WGV; DDL Diagnostic Laboratory, Rijswijk, the Netherlands., van Noesel CJM; Amsterdam UMC, University of Amsterdam, Department of Pathology, Amsterdam, the Netherlands., van der Wal AC; Amsterdam UMC, University of Amsterdam, Department of Pathology, Amsterdam, the Netherlands., Richel O; Amsterdam UMC, University of Amsterdam, Department of Internal Medicine, Division of Infectious Diseases, Amsterdam, the Netherlands.; Radboud University Medical Center, Department of Internal Medicine, Nijmegen, the Netherlands., Krebber WJTA; ISA Pharmaceuticals, Oegstgeest, the Netherlands., Melief CJM; ISA Pharmaceuticals, Oegstgeest, the Netherlands., de Vries HJC; Amsterdam UMC, University of Amsterdam, Department of Dermatology, Amsterdam Institute for Infection and Immunity (AI&II), Amsterdam, the Netherlands.; STI outpatient clinic, Department of Infectious Diseases, Public Health Service of Amsterdam (GGD Amsterdam), Amsterdam, the Netherlands., Prins JM; Amsterdam UMC, University of Amsterdam, Department of Internal Medicine, Division of Infectious Diseases, Amsterdam, the Netherlands.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Oct 13; Vol. 29 (20), pp. 4109-4117.
Autor:
Jansen DTSL; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, Netherlands., de Beijer MTA; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, Netherlands., Luijten RJ; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, Netherlands., Kwappenberg K; ISA Pharmaceuticals B.V., Oegstgeest, Netherlands., Wiekmeijer AS; ISA Pharmaceuticals B.V., Oegstgeest, Netherlands., Kessler AL; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, Netherlands., Pieterman RFA; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, Netherlands., Bouzid R; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, Netherlands., Krebber WJ; ISA Pharmaceuticals B.V., Oegstgeest, Netherlands., de Man RA; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, Netherlands., Melief CJM; ISA Pharmaceuticals B.V., Oegstgeest, Netherlands., Buschow SI; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, Netherlands.
Publikováno v:
Frontiers in immunology [Front Immunol] 2023 Sep 13; Vol. 14, pp. 1163118. Date of Electronic Publication: 2023 Sep 13 (Print Publication: 2023).
Autor:
Stegmann T; Mymetics BV, J.H, Oortweg 21, 2333 CH, Leiden, The Netherlands. toon.stegmann@mymetics.com., Wiekmeijer AS; ISA Pharmaceuticals BV, De Limes 7, 2342 DH, Oegstgeest, The Netherlands., Kwappenberg K; ISA Pharmaceuticals BV, De Limes 7, 2342 DH, Oegstgeest, The Netherlands., van Duikeren S; Immunology department, Leiden Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands., Bhoelan F; Mymetics BV, J.H, Oortweg 21, 2333 CH, Leiden, The Netherlands., Bemelman D; Mymetics BV, J.H, Oortweg 21, 2333 CH, Leiden, The Netherlands., Beenakker TJM; ISA Pharmaceuticals BV, De Limes 7, 2342 DH, Oegstgeest, The Netherlands., Krebber WJ; ISA Pharmaceuticals BV, De Limes 7, 2342 DH, Oegstgeest, The Netherlands., Arens R; Immunology department, Leiden Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands., Melief CJM; ISA Pharmaceuticals BV, De Limes 7, 2342 DH, Oegstgeest, The Netherlands.
Publikováno v:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2023 Aug; Vol. 72 (8), pp. 2851-2864. Date of Electronic Publication: 2023 May 24.
Autor:
Melief CJM; ISA Pharmaceuticals, Oegstgeest, The Netherlands. Melief@isa-pharma.com., van der Gracht E; ISA Pharmaceuticals, Oegstgeest, The Netherlands., Wiekmeijer AS; ISA Pharmaceuticals, Oegstgeest, The Netherlands.
Publikováno v:
Seminars in immunopathology [Semin Immunopathol] 2023 Mar; Vol. 45 (2), pp. 273-277. Date of Electronic Publication: 2023 Feb 13.
Autor:
Melief CJM; Leiden University Medical Center, Leiden, The Netherlands; ISA Pharmaceuticals, Leiden, The Netherlands. Electronic address: melief@isa-pharma.com.
Publikováno v:
Cell reports. Medicine [Cell Rep Med] 2022 Oct 18; Vol. 3 (10), pp. 100788.